Iodohippurate Sodium I 123

CHEMBL1200439 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
323.0 g/mol
LogP
Phase
4

A radioactive sodium salt of iodohippurate labeled with iodine-123, used as a kidney imaging agent to assess renal blood flow and function by nuclear medicine scanning. It is cleared rapidly by the kidneys, allowing doctors to evaluate how well each kidney is working.

Khối lượng phân tử

323,0500 g/mol

TPSA

69,20 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])CNC(=O)c1ccccc1[123I].[Na+]

InChI

InChI=1S/C9H8INO3.Na/c10-7-4-2-1-3-6(7)9(14)11-5-8(12)13;/h1-4H,5H2,(H,11,14)(H,12,13);/q;+1/p-1/i10-4;

Molecular Formula

C9H7INNaO3

HBD / HBA

1 / 3

Liên kết có thể quay

3

Nguyên tử nặng

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A radioactive sodium salt of iodohippurate labeled with iodine-123, used as a kidney imaging agent to assess renal blood flow and function by nuclear medicine scanning. It is cleared rapidly by the kidneys, allowing doctors to evaluate how well each kidney is working.

Yes, Iodohippurate Sodium I 123 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200439. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23667636. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.